ACR Appropriateness Criteria® Thyroid Disease
Jenny K. Hoang(Duke Medical Center), Amanda S. Corey(Boston Medical Center), H. Benjamin Harvey(Massachusetts General Hospital), Matthew T. Whitehead(Children's National), Bruno Policeni(University of Iowa Hospitals and Clinics), Julie Bykowski(University of California San Diego), Matthew S. Parsons(Mallinckrodt (United States)), Rathan M. Subramaniam(American College), Jorge D. Oldan(University of North Carolina Hospitals), Vikas Agarwal(University of Pittsburgh Medical Center), Gul Moonis(Columbia University Irving Medical Center), Tabassum A. Kennedy(UW Health University Hospital), Susan J. Mandel(American Thyroid Association), Jason W. Schroeder(Walter Reed National Military Medical Center), Amy F. Juliano(Massachusetts Eye and Ear Infirmary), Jeffrey S. Pannell(University of California San Diego Medical Center), Judah Burns(Montefiore Medical Center)
Cited by 31
Related Papers
Clinical Practice Guideline: Sudden Hearing Loss (Update)
|Otolaryngology|2019|918
Clinical Practice Guideline: Ménière’s Disease
|Otolaryngology|2020|301
Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial
|The Lancet Oncology|2021|257
Clinical Practice Guideline: Sudden Hearing Loss (Update) Executive Summary
|Otolaryngology|2019|155